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272a Monday, February 4, 2013unbinding with short (<100 ms) pulses of light and to follow channel activation
and desensitization in real-time. The experiments give insight into the gating
mechanism of GluK2 homotetramers and will be extended to study subunit spe-
cific activation in heteromeric GluK2/GluK5 complexes, which assemble with
defined 2:2 subunit stoichiometry [2].
1. Gorostiza P. et al., Proc. Natl. Acad. Sci. USA (2007) 104: 10865.
2. Reiner A. et al., Cell. Rep. (2012) 1: 234.
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Ionotropic glutamate (iGlu) receptors, including theNMDA andAMPA subfam-
ilies,mediate fast excitatory synaptic transmission in themammalian central ner-
vous system. NMDA and AMPA receptors play critical roles in learning and
memory and are implicated in multiple neurological and psychiatric diseases.
Argiotoxins (exemplified by the prototypical ArgTX-636) are so-called poly-
amine toxins isolated from the venom of the orb weaver spider Argiope lobata.
Argiotoxins consists of an aromatic head group coupled via an amino acid linker
to a polyamine moiety and act as open-channel blockers of the iGlu receptor ion
channel with nanomolar affinity. Structure-activity studies of synthetic argio-
toxin analogs have shown that modification of the polyamine tail can tweak
NMDA versus AMPA selectivity (REF NELSON ET AL). Furthermore, the ar-
omatic head group can tolerate substantial modification without loss of affinity.
The aim of the present study is to develop NMDA- and AMPA selective argio-
toxin analogs containing fluorescent moieties to enable imaging studies of na-
tive iGlu receptors and to serve as potential FRET donor or acceptor ligands.
Specifically, a series ArgTX-636 analogs with fluorescein, coumarin and
boron-dipyrromethene (BODIPY) derived fluorophores incoporated at or re-
placing the headgroup moiety were synthesized and characterized at recombi-
nant AMPA and NMDA receptors expressed in Xenopus Laevis oocytes
(GluA1 and GluN1/2A, respectively). Several analogs were found to posses
high-affinity NMDA and/or AMPA receptor binding while maintaining desir-
able fluorescent properties.
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Ionotropic glutamate receptors are tetrameric ion channels that are activated by
the neurotransmitter glutamate at excitatory synapses. It is known that after the
binding of glutamate, theAMPA-subtype of glutamate receptors transits through
distinct functional states to become fully activated, however, the conformations
sampled by the tetramer during activation remain unknown. We have subjected
plausiblemodels of the tetramer of ligand binding domains to a panel of trapping
bridges combined with electrophysiology, biochemistry and crystallography.
These experiments were designed to probe the geometry of the different states
sampled by the ligand binding domains during receptor activation. We show
that the mutant A665C is preferentially crosslinked in the presence of the partial
agonist, kainate. In addition, the same crosslink trapped amuchmore stable con-
formation in the desensitized state. We also resolved fast disulfide trapping on
themillisecond time scale in the resting state of the glutamate receptor, providing
insight into dynamics of the receptor complex at rest. Finally, we present engi-
neered metal trapping bridges that trap conformations distinct from those ob-
served in the full-length resting state crystal structure (Sobolevsky et al, 2009
Nature). Overall, our results reinforce the idea that the ligand binding domains
are highly flexible and sample a surprisingly large conformational space.
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GluK3 receptors belong to the family of kainate subtype ligand-gated gluta-
mate receptor ion channels. Experiments in Bordeaux revealed that zinc selec-
tively potentiated glutamate evoked currents for GluK3 while responses forGluK2 were inhibited. Mutagenesis and analysis of chimeric GluK2/GluK3 re-
ceptors mapped the zinc-binding site to the S2 segment of the ligand-binding
domain (LBD) in a region expected to form the interface between two
GluK3 subunits in an LBD dimer assembly. Multiple sequence alignments,
coupled with site directed mutagenesis, revealed that a GluK3 specific aspartate
residue, D759, which is exchanged for glycine in GluK1, GluK2 and in AMPA
receptors, was essential for zinc potentiation. To identify additional residues
contributing to the zinc binding site we attempted to solve a GluK3 LBD dimer
assembly crystal structure. This was hampered by formation of zinc mediated
intermolecular contacts between LBD monomers that favored other, non-
biologically relevant head to tail dimer assemblies in three crystal forms solved
for GluK3 glutamate and kainate complexes. However, from these structures
we could generate a model dimer assembly by least squares superimposition
of two copies of a GluK3 monomer on a previously solved GluK2 LBD dimer
structure. This revealed that adjustment of rotamers for D730, D759 and H762
would allow formation of intersubunit contacts with appropriate bonding dis-
tances for zinc coordination. Mutagenesis experiments confirm that D730 on
one subunit, together with D759 and H762 in the dimer partner, together
form the binding site for zinc potentiation. The model also revealed that zinc
acts as a countercharge that neutralizes the negative charges of the two coordi-
nating aspartate residues, thereby stabilizing the dimer assembly and reducing
desensitization. These results suggest that zinc may act as an endogenous pos-
itive allosteric modulator of native GluK3 containing kainate receptors.
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Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that play
a central role in brain function. They are important in neuronal communication
and are implicated in a host of neurological disorders such as schizophrenia and
depression. The free energy of agonist binding to the ligand-binding domains
(LBDs) of iGluRs is converted into useful work to induce conformational
changes that cause receptor activation. The free energies associated with ligand
docking and large-scale LBD conformational transitions have previously been
computed using an approach that evaluates the two processes separately. Here,
we employ a computational approach that treats ligand docking and LBD con-
formational transitions in a collective fashion. This enables the free energy
along a physical ligand-binding pathway to be evaluated. The kinetics associ-
ated with segments of this pathway are also evaluated.
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AMPA receptors (GluAs) are essential neuronal ligand-gated ion channels in-
volved in learning and memory. The dimeric conformation of the GluA2
ligand-binding domain is involved in the coupling of agonist binding to channel
gating. The desensitized state conformation has been shown to be disrupted
along the dimer interface, however little is known about the dynamic equilib-
rium of the resting or activated states. A simple dimerization model is solely
dependent on protein concentration, while the addition of allosteric modulator
shifts the equilibrium of dimerization. By binding to the dimer interface and in-
creasing the interface contacts, allosteric modulators enhance the stability of
the dimer. using small angle x-ray scattering (SAXS) and nuclear magnetic res-
onance (NMR), we screened both protein and allosteric modulator concentra-
tions to develop an equilibrium model for modulator dependent dimerization.
Depending on the specific interacting allosteric modulator, the symmetrical di-
mer interface can be occupied by one or two bound molecules. Both one-site
per dimer (R2L) and two-site per dimer (R2L2) models are explored. In addi-
tion, dimerization led to characteristic chemical shift changes along the dimer
interface as well as the ligand binding pocket. These changes have also been
detected on the ligand and support that dimerization modulates the multiple
conformational states involved in ligand binding. Our aim is to further under-
stand the mechanism by which the activation process is enhanced by allosteric
modulators.
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NMDA receptors are one of the three main types of ionotropic glutamate recep-
tors that mediate excitatory transmission and are tetramers typically composed
of glycine- binding (GluN1) subunits and glutamate- binding (GluN2) subunits.
NMDA receptors are unique in that they are allosterically modulated by zinc
